Nano Letters,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 17, 2024
Rapid
and
precise
cancer
subtype
discrimination
is
essential
for
personalized
oncology.
Conventional
diagnostic
methods
often
lack
sufficient
accuracy
speed.
Here,
we
introduce
a
multichannel
fluorescence-encoded
nanosystem
based
on
erythrocyte-coated
polydopamine
nanoparticles
(PDA@EM),
functionalized
with
multiple
resurfaced
fluorescent
proteins.
The
fluorescence
of
these
proteins
initially
quenched
by
PDA@EM
restored
upon
cell
addition.
This
enables
highly
sensitive
"turn-on"
profiling
cells
within
30
min,
achieving
100%
in
distinguishing
various
classifying
wide
range
lines,
including
subtypes
oral
squamous
carcinoma
(OSCC).
Notably,
it
offers
rapid,
label-free
diagnostics
OSCC
malignancy
from
clinical
samples
postsurgery.
capability
was
validated
through
histopathological
proteomic
analyses,
which
identified
protein
signatures
associated
tumor
progression
immune
suppression.
Overall,
our
nanosensor
represents
an
advanced
molecular
platform,
paving
the
way
treatment
Cells,
Journal Year:
2025,
Volume and Issue:
14(5), P. 382 - 382
Published: March 5, 2025
The
peremptory
need
to
circumvent
challenges
associated
with
poorly
differentiated
epithelial
endometrial
cancers
(PDEECs),
also
known
as
Type
II
(ECs),
has
prompted
therapeutic
interrogation
of
the
prototypically
intractable
and
most
prevalent
gynecological
malignancy.
PDEECs
account
for
cancer-related
mortalities
due
their
aggressive
nature,
late-stage
detection,
poor
response
standard
therapies.
are
characterized
by
heterogeneous
histopathological
features
distinct
molecular
profiles,
they
pose
significant
clinical
propensity
rapid
progression.
Regardless
complexities
around
PDEECs,
still
being
administered
inefficiently
in
same
manner
clinically
indolent
readily
curable
type-I
ECs.
Currently,
there
no
targeted
therapies
treatment
PDEECs.
realization
new
options
transformed
our
understanding
enabling
more
precise
classification
based
on
genomic
profiling.
transition
from
a
provided
critical
insights
into
underlying
genetic
epigenetic
alterations
these
malignancies.
This
review
explores
landscape
focus
identifying
key
subtypes
mutations
that
variants.
Here,
we
discuss
how
correlates
outcomes
can
refine
diagnostic
accuracy,
predict
patient
prognosis,
inform
strategies.
Deciphering
underpinnings
led
advances
precision
oncology
protracted
remissions
patients
untamable
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 4, 2024
Abstract
Self-supervised
learning
(SSL)
automates
the
extraction
and
interpretation
of
histopathology
features
on
unannotated
hematoxylin-and-eosin-stained
whole-slide
images
(WSIs).
We
trained
an
SSL
Barlow
Twins-encoder
435
TCGA
colon
adenocarcinoma
WSIs
to
extract
from
small
image
patches.
Leiden
community
detection
then
grouped
tiles
into
histomorphological
phenotype
clusters
(HPCs).
HPC
reproducibility
predictive
ability
for
overall
survival
was
confirmed
in
independent
clinical
trial
cohort
(N=1213
WSIs).
This
unbiased
atlas
resulted
47
HPCs
displaying
unique
sharing
clinically
significant
traits,
highlighting
tissue
type,
quantity,
architecture,
especially
context
tumor
stroma.
Through
in-depth
analysis
these
HPCs,
including
immune
landscape
gene
set
enrichment
analysis,
association
outcomes,
we
shed
light
factors
influencing
responses
treatments
like
standard
adjuvant
chemotherapy
experimental
therapies.
Further
exploration
may
unveil
new
insights
aid
decision-making
personalized
cancer
patients.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 21, 2025
Abstract
The
diagnosis
of
myelodysplastic
neoplasms
(MDS)
requires
examination
the
bone
marrow
for
morphologic
evidence
dysplasia.
We
sought
to
determine
if
a
self-supervised
learning
(SSL)
AI
image
analysis
approach
may
be
utilized
reliably
distinguish
MDS
from
its
clinically
relevant
mimics
using
biopsies
(BMBx).
Whole
slide
images
(WSIs)
H&E-
and
reticulin-stained
BMBx
sections
243
unique
patients
(89
MDS,
55
non-MDS
cytopenic
controls
[NMCC],
99
negative
control
[NC]
cases)
were
segmented
into
tiles
analyzed.
These
then
processed
Barlow
Twins
SSL
model
generate
histomorphologic
phenotype
clusters
(HPCs).
Review
HPCs
revealed
enriched
in
captured
known
histopathologic
features
including
hypercellularity,
dysplastic
clustered
megakaryocytes,
increased
immature
hematopoietic
cells,
vascularity,
fibrosis,
cell
streaming
patterns.
Assessment
95
second
institution
showed
consistent
HPC
enrichment
patterns,
validating
robustness
model.
trained
ensemble
slides
distinguished
NCs
with
an
AUC
0.89,
age-matched,
NMCCs
0.84.
findings
demonstrate
potential
approaches
capture
diagnostically
patterns
improve
reproducibility
diagnosis.
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 8, 2025
Abstract
Self-supervised
learning
(SSL)
automates
the
extraction
and
interpretation
of
histopathology
features
on
unannotated
hematoxylin-eosin-stained
whole
slide
images
(WSIs).
We
train
an
SSL
Barlow
Twins
encoder
435
colon
adenocarcinoma
WSIs
from
The
Cancer
Genome
Atlas
to
extract
small
image
patches
(tiles).
Leiden
community
detection
groups
tiles
into
histomorphological
phenotype
clusters
(HPCs).
HPC
reproducibility
predictive
ability
for
overall
survival
are
confirmed
in
independent
clinical
trial
(
N
=
1213
WSIs).
This
unbiased
atlas
results
47
HPCs
displaying
unique
shared
clinically
significant
traits,
highlighting
tissue
type,
quantity,
architecture,
especially
context
tumor
stroma.
Through
in-depth
analyses
these
HPCs,
including
immune
landscape
gene
set
enrichment
analyses,
associations
outcomes,
we
shine
light
factors
influencing
responses
treatments
standard
adjuvant
chemotherapy
experimental
therapies.
Further
exploration
may
unveil
additional
insights
aid
decision-making
personalized
cancer
patients.
Electronics,
Journal Year:
2025,
Volume and Issue:
14(7), P. 1252 - 1252
Published: March 22, 2025
The
early
detection
and
intervention
of
oral
squamous
cell
carcinoma
(OSCC)
using
histopathological
images
are
crucial
for
improving
patient
outcomes.
current
literature
identifying
OSCC
predominantly
relies
on
models
pre-trained
ImageNet
to
minimize
the
need
manual
data
annotations
in
model
fine-tuning.
However,
a
significant
divergence
exists
between
visual
domains
natural
images,
potentially
limiting
representation
transferability
these
models.
Inspired
by
recent
self-supervised
research,
this
work,
we
propose
HistoMoCo,
an
adaptation
Momentum
Contrastive
Learning
(MoCo),
designed
generate
with
enhanced
image
representations
initializations
images.
Specifically,
HistoMoCo
aggregates
102,228
leverages
structure
features
unique
histological
data,
allowing
more
robust
feature
extraction
subsequent
downstream
We
perform
tasks
evaluate
two
real-world
datasets,
including
NDB-UFES
Oral
Histopathology
datasets.
Experimental
results
demonstrate
that
consistently
outperforms
traditional
ImageNet-based
pre-training,
yielding
stable
accurate
performance
detection,
achieving
AUROC
up
99.4%
dataset
94.8%
dataset.
Furthermore,
dataset,
pre-training
solution
achieves
89.32%
40%
training
whereas
reaches
89.58%
only
10%
data.
addresses
issue
domain
state-of-the-art
More
importantly,
significantly
reduces
reliance
release
our
code
parameters
further
research
histopathology
or
tasks.
npj Precision Oncology,
Journal Year:
2024,
Volume and Issue:
8(1)
Published: Oct. 16, 2024
Precise
survival
risk
stratification
is
crucial
for
personalized
therapy
in
bladder
cancer
(BCa).
This
study
developed
and
validated
an
end-to-end
deep
learning
system
using
histological
slides
to
predict
overall
(OS)
BCa
patients.
We
employed
the
BlaPaSeg
tile
classifier
generate
tissue
probability
heatmaps
segmentation
maps,
trained
two
prognostic
networks,
MacroVisionNet
UniVisionNet,
explored
six
potential
biomarkers.
Across
all
cohorts,
AUC
ranged
from
0.9906
0.9945,
while
C-index
varied
0.655
0.834
0.661
0.853
UniVisionNet.
After
covariate
adjustment,
hazard
ratio
(HR)
values
high-risk
groups
were
1.97
5.06
2.13
4.01
The
Coloc
(Tumor
Co-localization
score)
IMTS
(Integrated
Muscle
Tumor
Score)
illustrated
a
higher
death
with
HR
1.41
10.16.
improves
prediction
supports
refined
patient
management.
EClinicalMedicine,
Journal Year:
2024,
Volume and Issue:
77, P. 102888 - 102888
Published: Nov. 1, 2024
SummaryBackgroundThis
study
explores
the
potential
of
deep
learning-based
convolutional
neural
network
(CNN)
to
automatically
recognize
MMD
using
MRA
images
from
atherosclerotic
disease
(ASD)
and
normal
control
(NC).MethodsIn
this
retrospective
in
China,
600
participants
(200
MMD,
200
ASD
NC)
were
collected
one
institution
as
an
internal
dataset
for
training
60
another
external
testing
set
validation.
All
divided
into
(N
=
450)
validation
sets
90),
60),
60).
The
input
CNN
models
comprised
preprocessed
images,
while
output
was
a
tripartite
classification
label
that
identified
patient's
diagnostic
group.
performances
3D
evaluated
comprehensive
metrics
such
area
under
curve
(AUC)
accuracy.
Gradient-weighted
Class
Activation
Mapping
(Grad-CAM)
used
visualize
CNN's
decision-making
process
diagnosis
by
highlighting
key
areas.
Finally,
compared
with
those
two
experienced
radiologists.FindingsDenseNet-121
exhibited
superior
discrimination
capabilities,
achieving
macro-average
AUC
0.977
(95%
CI,
0.928–0.995)
test
0.880
0.786–0.937)
sets,
thus
exhibiting
comparable
capabilities
human
radiologists.
In
binary
where
NC
group
together,
separate
targeted
detection,
DenseNet-121
achieved
accuracy
0.967
0.886–0.991).
Additionally,
Grad-CAM
results
areas
intense
redness
indicating
critical
model,
reflected
similar
experts.InterpretationThis
highlights
efficacy
model
automated
on
easing
workload
radiologists
promising
integration
clinical
workflows.FundingNational
Natural
Science
Foundation
Tianjin
Technology
Project
Beijing
Foundation.
Frontiers in Oncology,
Journal Year:
2024,
Volume and Issue:
14
Published: Dec. 23, 2024
Artificial
intelligence
(AI)
has
significantly
impacted
various
fields,
including
oncology.
This
comprehensive
review
examines
the
current
applications
and
future
prospects
of
AI
in
lung
cancer
research
treatment.
We
critically
analyze
latest
technologies
their
across
multiple
domains,
genomics,
transcriptomics,
proteomics,
metabolomics,
immunomics,
microbiomics,
radiomics,
pathomics
research.
The
elucidates
AI’s
transformative
role
enhancing
early
detection,
personalizing
treatment
strategies,
accelerating
therapeutic
innovations.
explore
impact
on
precision
medicine
cancer,
encompassing
diagnosis,
planning,
monitoring,
drug
discovery.
potential
analyzing
complex
datasets,
genetic
profiles,
imaging
data,
clinical
records,
is
discussed,
highlighting
its
capacity
to
provide
more
accurate
diagnoses
tailored
plans.
Additionally,
we
examine
predicting
patient
responses
immunotherapy
forecasting
survival
rates,
particularly
non-small
cell
(NSCLC).
addresses
technical
challenges
facing
implementation
care,
data
quality
quantity
issues,
model
interpretability,
ethical
considerations,
while
discussing
solutions
emphasizing
importance
rigorous
validation.
By
providing
a
analysis
for
researchers
clinicians,
this
underscores
indispensable
combating
usher
new
era
medical
breakthroughs,
ultimately
aiming
improve
outcomes
life.